The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.
Therapeutic inertia in the treatment of hyperglycaemia in patients with type 2 diabetes: A systematic review
Open accessAbstract
Aims: Therapeutic inertia, defined as the failure to initiate or intensify therapy in a timely manner according to evidence‐based clinical guidelines, is a key reason for uncontrolled hyperglycaemia in patients with type 2 diabetes. The aims of this systematic review were to identify how therapeutic inertia in the management of hyperglycaemia was measured and to assess its extent over the past decade. Materials and Methods: Systematic searches for articles published from January 1, 2004 to August 1, 2016 were conducted in MEDLINE and Embase. Two researchers independently screened all of the titles and abstracts, and the full texts of publications deemed relevant. Data were extracted by a single researcher using a standardized data extraction form. Results: The final selection for the review included 53 articles. Measurements used to assess therapeutic inertia varied across studies, making comparisons difficult. Data from low‐ to middle‐income countries were scarce. In most studies, the median time to treatment intensification after a glycated haemoglobin (HbA1c) measurement above target was more than 1 year (range 0.3 to >7.2 years). Therapeutic inertia increased as the number of antidiabetic drugs rose and decreased with increasing HbA1c levels. Data were mainly available from Western countries. Diversity of inertia measures precluded meta‐analysis. Conclusions: Therapeutic inertia in the management of hyperglycaemia in patients with type 2 diabetes is a major concern. This is well documented in Western countries, but corresponding data are urgently needed in low‐ and middle‐income countries, in view of their high prevalence of type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
International Diabetes Federation 2017
Carracher, A. M., Marathe, P. H., & Close, K. L. (2018) · Journal of Diabetes · doi:10.1111/1753-0407.12644 · Cited by 13,418
Stratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059
Standards of Medical Care in Diabetes
Power, D. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1593 · Cited by 8,673
Turner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
Standards of medical care in diabetes—2014
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s014 · Cited by 4,572
Gupta, A., & Uribarri, J. (2016) · Hormone Research in Paediatrics · doi:10.1159/000444053 · Cited by 4,006
Inzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R., & Matthews, D. R. (2015) · Diabetes Care · doi:10.2337/dc14-2441 · Cited by 3,066
Ray, K. K., Seshasai, S. R. K., Wijesuriya, S., Sivakumaran, R., Nethercott, S., Preiss, D., Erqou, S., & Sattar, N. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60697-8 · Cited by 1,383
Resistance to Insulin Therapy Among Patients and Providers
Peyrot, M., Rubin, R. R., Lauritzen, T., Skovlund, S. E., Snoek, F. J., Matthews, D. R., Landgraf, R., Kleinebreil, L., & Panel, O. B. O. T. I. D. A. (2005) · Diabetes Care · doi:10.2337/diacare.28.11.2673 · Cited by 783
Inzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R., & Matthews, D. R. (2015) · Diabetologia · doi:10.1007/s00125-014-3460-0 · Cited by 694
Clinical Inertia in People With Type 2 Diabetes
Khunti, K., Wolden, M. L., Thorsted, B. L., Andersen, M., & Davies, M. J. (2013) · Diabetes Care · doi:10.2337/dc13-0331 · Cited by 613
Self-citationWolff, L. F., Smith, Q. T., Snyder, W. K., Bedrick, J. A., Liljemark, W. F., Aeppli, D. A., & Bandt, C. L. (1988) · Journal of Clinical Periodontology · doi:10.1111/j.1600-051x.1988.tb01003.x · Cited by 577
The Burden of Treatment Failure in Type 2 Diabetes
Brown, J. B., Nichols, G. A., & Perry, A. (2004) · Diabetes Care · doi:10.2337/diacare.27.7.1535 · Cited by 424
Qaseem, A., Humphrey, L. L., Sweet, D. E., Starkey, M., Shekelle, P., & for the Clinical Guidelines Committee of the American College of Physicians* (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-156-3-201202070-00011 · Cited by 400
Clinical Inertia in Response to Inadequate Glycemic Control
Shah, B. R., Hux, J. E., Laupacis, A., Zinman, B., & van Walraven, C. (2005) · Diabetes Care · doi:10.2337/diacare.28.3.600 · Cited by 388
Individualizing Glycemic Targets in Type 2 Diabetes Mellitus: Implications of Recent Clinical Trials
Ismail-Beigi, F., Moghissi, E., Tiktin, M., Hirsch, I. B., Inzucchi, S. E., & Genuth, S. (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-154-8-201104190-00007 · Cited by 386
Paul, S. K., Klein, K., Thorsted, B. L., Wolden, M. L., & Khunti, K. (2015) · Cardiovascular Diabetology · doi:10.1186/s12933-015-0260-x · Cited by 298
Self-citationQuality of Care of People With Type 2 Diabetes in Eight European Countries
Stone, M. A., Charpentier, G., Doggen, K., Kuss, O., Lindblad, U., Kellner, C., Nolan, J., Pazderska, A., Rutten, G., Trento, M., et al. (2013) · Diabetes Care · doi:10.2337/dc12-1759 · Cited by 257
Self-citationKhunti, K., Nikolajsen, A., Thorsted, B. L., Andersen, M., Davies, M. J., & Paul, S. K. (2016) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12626 · Cited by 256
Self-citationBarriers to Insulin Initiation
Karter, A. J., Subramanian, U., Saha, C., Crosson, J. C., Parker, M. M., Swain, B. E., Moffet, H. H., & Marrero, D. G. (2010) · Diabetes Care · doi:10.2337/dc09-1184 · Cited by 254
Schmittdiel, J. A., Uratsu, C. S., Karter, A. J., Heisler, M., Subramanian, U., Mangione, C. M., & Selby, J. V. (2008) · Journal of General Internal Medicine · doi:10.1007/s11606-008-0554-8 · Cited by 239
AACE/ACE comprehensive diabetes management algorithm 2015
Garber, A. J., Abrahamson, M. J., Barzilay, J. I., Blonde, L., Bloomgarden, Z. T., Bush, M. A., Dagogo-Jack, S., Davidson, M. B., Einhorn, D., Garber, J. R., et al. (2015) · Endocrine Practice · doi:10.4158/ep15693.cs · Cited by 225
de Pablos‐Velasco, P., Parhofer, K. G., Bradley, C., Eschwège, E., Gönder-Frederick, L., Maheux, P., Wood, I., & Simon, D. (2014) · Clinical Endocrinology · doi:10.1111/cen.12119 · Cited by 218 · cited 1×
“achieved the recommended HbA1c target of ≤7% (53 mmol/ mol).(11,12) Several studies have identified 2 main reasons for suboptimal glycaemic control in clinical practice: (1) patient non-adherence to prescribed treatment and (2) clinical or therapeutic inertia, defined as the failure to initiate or intensify therapy in…”
BackgroundGrant, R., Adams, A. S., Trinacty, C. M., Zhang, F., Kleinman, K., Soumerai, S. B., Meigs, J. B., & Ross-Degnan, D. (2007) · Diabetes Care · doi:10.2337/dc06-2170 · Cited by 218
Clinical Inertia Contributes to Poor Diabetes Control in a Primary Care Setting
Ziemer, D. C., Miller, C. D., Rhee, M. K., Doyle, J. P., Watkins, C., Cook, C. B., Gallina, D. L., El-Kebbi, I. M., Barnes, C. S., Dunbar, V. G., et al. (2005) · The Diabetes Educator · doi:10.1177/0145721705279050 · Cited by 208
Competing Demands or Clinical Inertia: The Case of Elevated Glycosylated Hemoglobin
Parchman, M. L., Pugh, J. A., Romero, R. L., & Bowers, K. W. (2007) · The Annals of Family Medicine · doi:10.1370/afm.679 · Cited by 207
Nakar, S., Yitzhaki, G., Rosenberg, R., & Vinker, S. (2007) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2006.02.004 · Cited by 159
Clinical inertia in the management of Type 2 diabetes metabolic risk factors
Grant, R. W., Cagliero, E., Dubey, A. K., Gildesgame, C., Chueh, H. C., Barry, M. J., Singer, D. E., Nathan, D. M., & Meigs, J. B. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01095.x · Cited by 158
Rubino, A., McQuay, L. J., Gough, S. C. L., Kvasz, M., & Tennis, P. S. (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02279.x · Cited by 155
Katon, W. J., Russo, J. E., Lin, E. H. B., Heckbert, S. R., Karter, A. J., Williams, L. H., Ciechanowski, P. S., Ludman, E. J., & Korff, M. V. (2009) · Psychosomatic Medicine · doi:10.1097/psy.0b013e3181bd8f55 · Cited by 148
Reasons for not intensifying medications: differentiating “clinical inertia” from appropriate care
Safford, M. M., Shewchuk, R., Qu, H., Williams, J. H., Estrada, C. A., Ovalle, F., & Allison, J. J. (2007) · Journal of General Internal Medicine · doi:10.1007/s11606-007-0433-8 · Cited by 132
Reed, M., Huang, J., Graetz, I., Brand, R., Hsu, J., FIREMAN, B. H., & Jaffe, M. G. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-7-201210020-00004 · Cited by 117
Li, Y., Qi, Y., Huang, T. H.-W., Yamahara, J., & Roufogalis, B. D. (2007) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2007.00708.x · Cited by 116
Ziemer, D. C., Doyle, J. P., Barnes, C. S., Branch, W. T., Cook, C. B., El-Kebbi, I. M., Gallina, D. L., Kolm, P., Rhee, M. K., & Phillips, L. S. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.5.507 · Cited by 110
Developing a Quality Measure for Clinical Inertia in Diabetes Care
Berlowitz, D. R., Ash, A. S., Glickman, M. E., Friedman, R. H., POGACH, L. M., Nelson, A. L., & Wong, A. T. (2005) · Health Services Research · doi:10.1111/j.1475-6773.2005.00436.x · Cited by 109
Zafar, A., Stone, M. A., Davies, M. J., & Khunti, K. (2015) · Diabetic Medicine · doi:10.1111/dme.12592 · Cited by 103
Self-citationClinical inertia in general practice: widespread and related to the outcome of diabetes care
van Bruggen, R., Gorter, K. J., Stolk, R. P., Klungel, O. H., & Rutten, G. E. H. M. (2009) · Family Practice · doi:10.1093/fampra/cmp053 · Cited by 93
Inercia y cumplimiento terapéutico en pacientes con diabetes mellitus tipo 2 en atención primaria
López‐Simarro, F., Brotons, C., Moral, I., Cols-Sagarra, C., Selva, A., Aguado-Jodar, A., & Miravet-Jiménez, S. (2011) · Medicina Clínica · doi:10.1016/j.medcli.2011.07.023 · Cited by 81
Treatment intensification in patients with type 2 diabetes who failed metformin monotherapy
Fu, A. Z., Qiu, Y., Davies, M. J., Radican, L., & Engel, S. S. (2011) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01405.x · Cited by 78
Treatment Intensification and Risk Factor Control: Toward More Clinically Relevant Quality Measures
Selby, J. V., Uratsu, C. S., FIREMAN, B. H., Schmittdiel, J. A., Peng, T., Rodondi, N., Karter, A. J., & Kerr, E. A. (2009) · Medical Care · doi:10.1097/mlr.0b013e31818d775c · Cited by 75
Clinical inertia in the treatment of hyperglycemia in type 2 diabetes patients in primary care
Mata-Cases, M., Benito-Badorrey, B., Roura-Olmeda, P., Franch-Nadal, J., Pepió-Vilaubí, J. M., Saez, M., Coll-de-Tuero, G., & on behalf of the GEDAPS (Primary Care Group for the study of Diabetes) of the Catalonian Society of Family and Community Medicine (2013) · Current Medical Research and Opinion · doi:10.1185/03007995.2013.833089 · Cited by 70
Mateo, J. F., Gil-Guillén, V. F., Mateo, E., Orozco‐Beltrán, D., Herencia, J. A. C., & Merino, J. (2006) · International Journal of Clinical Practice · doi:10.1111/j.1368-5031.2006.00799.x · Cited by 68
Clinical Inertia of Discharge Planning among Patients with Poorly Controlled Diabetes Mellitus
Griffith, M. L., Boord, J. B., Eden, S., & Matheny, M. E. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3216 · Cited by 68
Predictors and Impact of Intensification of Antihyperglycemic Therapy in Type 2 Diabetes
McEwen, L. N., Bilik, D., Johnson, S. L., Halter, J. B., Karter, A. J., Mangione, C. M., Subramanian, U., Waitzfelder, B. E., Crosson, J. C., & Herman, W. H. (2009) · Diabetes Care · doi:10.2337/dc08-1911 · Cited by 68
Sidorenkov, G. A., Haaijer‐Ruskamp, F. M., de Zeeuw, D., & Denig, P. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024278 · Cited by 60
Diabetes management in the real world and the impact of adherence to guideline recommendations
Lian, J., & Liang, Y. M. (2014) · Current Medical Research and Opinion · doi:10.1185/03007995.2014.952716 · Cited by 59
Lin, J., Zhou, S., Wei, W., Pan, C., Lingohr-Smith, M., & Levin, P. (2016) · Endocrine Practice · doi:10.4158/ep15868.or · Cited by 52
Treatment intensification for patients with type 2 diabetes and poor glycaemic control
Fu, A. Z., & Sheehan, J. J. (2016) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12683 · Cited by 52
Osataphan, S., Chalermchai, T., & Ngaosuwan, K. (2017) · Journal of Diabetes · doi:10.1111/1753-0407.12410 · Cited by 49
Bolen, S. D., Bricker, E., Samuels, T. A., Yeh, H., Marinopoulos, S. S., McGuire, M., Abuid, M., & Brancati, F. L. (2008) · Diabetes Care · doi:10.2337/dc08-1297 · Cited by 48
Anjana, R. M., Shanthirani, C. S., Ranjit Unnikrishnan, I., Poongkunran, M., Amutha, A., Nair, H. D., Subhashini, S., Venkatesan, U., Ali, M. K., Ranjani, H., et al. (2014) · Acta Diabetologica · doi:10.1007/s00592-014-0701-0 · Cited by 47
The effect of cumulative glycemic burden on the incidence of diabetic foot disease
Dekker, R. G., Qin, C. D., Ho, B. S., & Kadakia, A. R. (2016) · Journal of Orthopaedic Surgery and Research · doi:10.1186/s13018-016-0474-y · Cited by 46
Family Physician Clinical Inertia in Glycemic Control among Patients with Type 2 Diabetes
Kranjčević, K. (2015) · Medical Science Monitor · doi:10.12659/msm.892248 · Cited by 39
Balkau, B., Bouée, S., Avignon, A., Vergès, B. L., Chartier, I., Amelineau, E., & Halimi, S. (2012) · Diabetes & Metabolism · doi:10.1016/s1262-3636(12)71532-x · Cited by 38
Conthe, P., Mata‐Cases, M., Orozco‐Beltrán, D., Pajuelo, F., Barreto, C. S., Anaya, S. F., & Gomis, R. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2010.10.002 · Cited by 35
Voorham, J., Haaijer‐Ruskamp, F. M., Wolffenbuttel, B. H. R., de Zeeuw, D., Stolk, R. P., & Denig, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038707 · Cited by 32
Escalada, J., Orozco‐Beltrán, D., Morillas, C., Guisasola, F. Á., Peralta, F. G., Mata‐Cases, M., Palomares, R., Iglesias, R., & Carratalá‐Munuera, C. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.10.003 · Cited by 32
González-Clemente, J. M., Font, B., Lahoz, R., Llauradó, G., & Gambús, G. (2013) · Medicina Clínica · doi:10.1016/j.medcli.2013.02.032 · Cited by 30
Rajpathak, S. N., Rajgopalan, S., & Engel, S. S. (2014) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2014.06.004 · Cited by 29
Low, S. K., Lim, S. C., Yeoh, L. Y., Liu, A. Y. L., Liu, J., Fun, S., Su, C., Zhang, X., Subramaniam, T., & Sum, C. F. (2016) · Journal of Diabetes · doi:10.1111/1753-0407.12512 · Cited by 28
Reutens, A. T., Hutchinson, R., Binh, T. V., Cockram, C. S., Deerochanawong, C., Ho, L., Ji, L., Khalid, B. A. K., Kong, A. P. S., Lim-Abrahan, M. A., et al. (2012) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.06.002 · Cited by 27
Clinical Decisions Regarding HbA1c Results in Primary Care
Parnes, B. L., Main, D. S., Dickinson, L. M., Niebauer, L., Holcomb, S., Westfall, J. M., & Pace, W. D. (2004) · Diabetes Care · doi:10.2337/diacare.27.1.13 · Cited by 27
Schwab, P., Saundankar, V., Bouchard, J. R., Wintfeld, N., Suehs, B. T., Moretz, C., Allen, E., & Deluzio, A. (2016) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2015-000099 · Cited by 23
Nichols, G. A., Rosales, A. G., Perrin, N., & Fortmann, S. P. (2013) · Diabetes Care · doi:10.2337/dc13-1300 · Cited by 21
Consequences of delaying treatment intensification in type 2 diabetes: evidence from a UK database
Watson, L., Das, R., Farquhar, R., Langerman, H., & Barnett, A. H. (2016) · Current Medical Research and Opinion · doi:10.1185/03007995.2016.1157462 · Cited by 21
Yu, S., Schwab, P., Bian, B., Radican, L., & Tunceli, K. (2016) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2016.22.3.272 · Cited by 20
Huang, L., Shau, W., Yeh, H., Chen, T., Hsieh, J. Y., Su, S., & Lai, M. (2014) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.367 · Cited by 19
Ajmera, M., Raval, A. D., Zhou, S., Wei, W., Bhattacharya, R., Pan, C., & Sambamoorthi, U. (2015) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2015.21.12.1184 · Cited by 19
de Vries, S. T., Voorham, J., Haaijer‐Ruskamp, F. M., & Denig, P. (2014) · Diabetes Care · doi:10.2337/dc13-1861 · Cited by 18
Halimi, S., Balkau, B., Attali, C., Detournay, B., Amelineau, E., & Blickle, J. (2012) · Diabetes & Metabolism · doi:10.1016/s1262-3636(12)71533-1 · Cited by 16
Adjustments to Diabetes Medications in Response to Increases in Hemoglobin A1c
Davis, J. W., Chavez, B., & Taira, D. A. (2014) · Annals of Pharmacotherapy · doi:10.1177/1060028013517870 · Cited by 16
Sidorenkov, G. A., Voorham, J., Haaijer‐Ruskamp, F. M., de Zeeuw, D., & Denig, P. (2012) · Medical Care · doi:10.1097/mlr.0b013e318277eaf5 · Cited by 15
Do Treatment Quality Indicators Predict Cardiovascular Outcomes in Patients with Diabetes?
Sidorenkov, G. A., Voorham, J., de Zeeuw, D., Haaijer‐Ruskamp, F. M., & Denig, P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078821 · Cited by 14
Egan, B. M., Shaftman, S. R., Wagner, C. S., Bandyopadhyay, D., & Szymanski, K. A. (2012) · PubMed · Cited by 12
Mental illness and intensification of diabetes medications: an observational cohort study
Frayne, S. M., Holmes, T. H., Berg, E., Goldstein, M. K., Berlowitz, D. R., Miller, D. R., POGACH, L. M., Laungani, K. J., Lee, T. T., & Moos, R. H. (2014) · BMC Health Services Research · doi:10.1186/1472-6963-14-458 · Cited by 11
Tunceli, K., Goldshtein, I., Yu, S., Sharon, O., Brodovicz, K. G., Gadir, N., Katzeff, H. L., Voss, B., Radican, L., Chodick, G., et al. (2015) · Diabetes Management · doi:10.2217/dmt.14.45 · Cited by 9
Race as a Factor for Intensification of Diabetes Medications
Bullock, K. C., Edwards, K. L., Greene, R. S., Shah, S. R., & Blaszczyk, A. T. (2013) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721713479145 · Cited by 3
Cited by
Samson, S. L., Vellanki, P., Blonde, L., Christofides, E. A., Galindo, R. J., Hirsch, I. B., Isaacs, S. D., Izuora, K. E., Low Wang, C. C., Twining, C. L., et al. (2023) · Endocrine Practice · doi:10.1016/j.eprac.2023.02.001 · Cited by 375
Glycemia Reduction in Type 2 Diabetes — Glycemic Outcomes
The GRADE Study Research Group (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2200433 · Cited by 222
Addressing Clinical Inertia in Type 2 Diabetes Mellitus: A Review
Okemah, J., Peng, J., & Quiñones, M. (2018) · Advances in Therapy · doi:10.1007/s12325-018-0819-5 · Cited by 211
Khunti, S., Khunti, K., & Seidu, S. (2019) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018819844694 · Cited by 182
Self-citationPhillip, M., Bergenstal, R. M., Close, K. L., Danne, T., Garg, S. K., Heinemann, L., Hirsch, I. B., Kovatchev, B. P., Laffel, L. M., Mohan, V., et al. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2020.0375 · Cited by 135
Metadata
- Authors
- Khunti, K., Gomes, M. B., Pocock, S., Shestakova, M. V., Pintat, S., Fenici, P., Hammar, N., & Medina, J.
- Venue
- Diabetes, Obesity and Metabolism
- Publisher
- Wiley
- Published
- 2017-10
- Volume
- 20
- Issue
- 2
- Pages
- 427-437
- ISSN
- 1462-8902 (ISSN-L)
- 1463-1326
- OpenAlex
- W2748858803
- Cited by
- 367
- References
- 80
- FWCI
- 4.95
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.